logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

Free schools – missing the target?

13 July 2012

The debate over the introduction of free schools continues with new reports that the system of approving proposals is not adequately targeting areas where new schools and new ideas are required. The reports suggest that with free schools being proposed where there are already sufficient school places or where there is insufficient community support for another school, the free schools programme is missing its primary aim – to close the attainment gap between the “haves” and “have-nots” through new schools being created by parents and other groups within that community.

Whilst there is much to be said for the government’s “less is more” approach to red tape and bureaucracy, here it is only leading to more negative comments on the free schools programme. Clear guidelines on what may constitute a worthwhile proposal can only assist in providing a better understanding of the programme and its aims for all stakeholders, including those who wish to propose a school.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up